secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001193125-25-273317
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q3: revenue $700M, adj. EBITDA margin 25%, core growth 5% YoY
-------------------------------------------------------------------------

- Total revenue $700M; core revenue (ex-COVID/Donor Screening) grew 5% as reported.
- Adjusted EBITDA margin improved 180 bps to 25%; full-year guidance maintained at 22%.
- Labs +4%, IH +5%, Triage +7% (constant currency); non-respiratory up 6% CC.
- Respiratory revenue $112M (-32% YoY); COVID sales down 63%.
- Pending LEX Diagnostics acquisition on track; VITROS High Sensitivity Troponin cleared in U.S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000119312525273317/0001193125-25-273317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000119312525273317/d79385d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-273317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer